Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone

Labrie, Fernand, Luu-The, Van, Labrie, Claude, Bélanger, Alain, Simard, Jacques, Lin, Sheng-Xiang, Pelletier, Georges·2003·Endocrine Reviews

Cited by (545)

Items 501–545 of 545

  1. The Passing of Dr. Fernand Labrie (1937–2019): The legacy of excellence in science
    André Tchernof, Sheng Xiang Lin, Van Luu-The, Jacques Simard · 2019 · The Journal of Steroid Biochemistry and Molecular Biology
  2. Antiproliferative Activity of Spironolactone: In Vitro Study
    Mohammed A. Taher · 2018 · Iraqi Journal of Cancer and Medical Genetics
  3. Effects of ⧍-5 and ⧍-4 Androgens on the Brain
    Nicola Pluchino, Andrea Riccardo Genaz zani, Gynaecologist · 2008 · touchREVIEWS in Endocrinology
  4. Menopause Symptoms
    Debra L. Barton, Sherry L. Wolf · 2010 · Springer eBooks
  5. Reprint of “In vitro and in vivo evaluation of a 3β-androsterone derivative as inhibitor of 17β-hydroxysteroid dehydrogenase type 3”
    Jenny Roy, Michelle-Audrey Fournier, René Maltais, Lucie Carolle Kenmogne, Donald Poirier · 2015 · The Journal of Steroid Biochemistry and Molecular Biology
  6. Testosterone Therapy and Women‗s Sexuality
    Valeria Valentino, Giovanna Simi, Chiara Naninixy · 2007 · touchREVIEWS in Endocrinology
  7. Regulação hormonal da prostata feminina do gerbilo da Mongolia
    Ana Maria Galvan Custodio · 2007
  8. Expresión de los ARNm que codifican para las enzimas que biotransforman a la testosterona en células humanas de carcinoma mamario
    Leticia González Núñez · 2007
  9. Stress and Androgens in Himba Women
    Sean P. Prall, Brooke A. Scelza, Benjamin C. Trumble · 2023 · Adaptive Human Behavior and Physiology
  10. The impact of menopause and serum DHEA-S level on the severity of Covid-19
    Cemal Tamer Erel, İpek Betül Özçivit Erkan, Neslihan Gökmen İnan · 2023 · Maturitas
  11. A Narrative Review of the Vascular Consequences of Estrogen Deficiency: A Focus on Female Athletes with Functional Hypothalamic Amenorrhea
    Emma O’Donnell, Paula Harvey · 2023 · Advances in biochemistry in health and disease
  12. Associations of tubal ligation and hysterectomy with serum androgen and estrogen metabolites among postmenopausal women in the Women’s Health Initiative Observational Study
    Ashley M. Geczik, Kara A. Michels, Garnet L. Anderson, Roni T. Falk, Leslie V. Farland, JoAnn E. Manson, Aladdin H. Shadyab, Ruth M. Pfeiffer, Xia Xu, Britton L. Trabert · 2024 · Cancer Causes & Control
  13. Traditional practices in CNS drug delivery
    Gurmeet Singh, Amandeep Singh, Rohit Bhatia, Rajveer Singh, Dilpreet Kaur, Raj Kumar Narang · 2024 · Elsevier eBooks
  14. 10.1016/b978-1-4160-2911-3.50021-2
    2000 · Time to knit
  15. The association between androgen receptor expression and some pathological characteristics in patients with breast cancer
    Mahdokht Azizi, Seyed Madani, Babak Izadi · 2021 · Clinical Cancer Investigation Journal
  16. アルドステロン研究から心臓ステロイド研究へ(4.心血管内分泌系 : アンジオテンシン受容体・アルドステロン受容体研究の新展開)(<特集II>第68回日本循環器学会学術集会)
    吉村 道博 · 2005 · Journal of JCS Cardiologists
  17. Additional file 5 of Transcriptome characterization of BPG axis and expression profiles of ovarian steroidogenesis-related genes in the Japanese sardine
    Nyuji, Mitsuo, Hongo, Yuki, Yoneda, Michio · 2020 · Figshare
  18. Additional file 2 of Transcriptome characterization of BPG axis and expression profiles of ovarian steroidogenesis-related genes in the Japanese sardine
    Nyuji, Mitsuo, Hongo, Yuki, Yoneda, Michio · 2020 · Figshare
  19. Additional file 8 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  20. Additional file 5 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  21. Additional file 11 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  22. Additional file 10 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  23. Additional file 9 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  24. Additional file 12 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  25. Additional file 6 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  26. Additional file 14 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  27. Additional file 15 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  28. Additional file 4 of Transcriptome characterization of BPG axis and expression profiles of ovarian steroidogenesis-related genes in the Japanese sardine
    Nyuji, Mitsuo, Hongo, Yuki, Yoneda, Michio · 2020 · Figshare
  29. Additional file 2 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  30. Additional file 13 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  31. Additional file 4 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  32. Additional file 7 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  33. Additional file 1 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  34. Additional file 3 of Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli, Hassan Yousefi, Isabella Van Savage, Samuel C. Okpechi, Maryl K. Wright, Margarite D. Matossian, Bridgette M. Collins‐Burow, Burow, Matthew E., Suresh K. Alahari · 2022 · Figshare
  35. NAD boosting by CD38 inhibition drives reversal of a pathological vicious cycle of intracrine activity and inflammation in eyelid meibomian gland involution
    Yuki Hamada, Takehide Sakamoto, Daisuke Yarimizu, Hikari Uehara, Xinyan Shao, Tom Macpherson, Emi Hasegawa, Masao Doi · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Association Between Sarcopenia Index and Central Obesity: Age- and Gender-Specific Patterns and Clinical Implications
    Ya-Hui Lee, Wen-Bin Bai, Yueh Lin, Guo-Tao Su, Wen-Cheng Li · 2026 · International Journal of General Medicine
  37. NAD boosting mediated by CD38 inhibition drives reversal of a pathological vicious cycle of intracrine activity and inflammation in eyelid meibomian gland dysfunction
    Yuki Hamada, Takehide Sakamoto, Daisuke Yarimizu, Hikari Uehara, Xinyan Shao, Tom Macpherson, Emi Hasegawa, Masao Doi · 2026 · eLife
  38. Rôle de la signalisation PKA dans la zonation de la glande surrénale : modèles génétiques murins et mécanismes post-traductionnels
    Typhanie Dumontet · 2017 · theses.fr (ABES)
  39. Contribution à l’étude des mécanismes de sensibilité aux traitements antiandrogènes dans les cancers du sein moléculaires apocrines
    Thomas Grellety · 2018
  40. Intracrinology and Testosterone Pellet Therapy: An Enzyme-Aware, Symptom-Driven Approach to Hormone Optimization in Aging
    Rebecca L. Glaser · 2026 · Cureus · Retracted
  41. Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety
    Juana Montero Bernaldez, Elizabeth R Burgess, Rebeca Martinez, Manuel Peñalver · 2026 · Cureus
  42. Near-infrared spectroscopy with chemometric analysis distinguishes genitourinary syndrome of menopause in vaginal samples
    Iaponira da Silva Figueiredo Vidal, Amaxsell Thiago Barros de Souza, Lidiane G. Silva · 2026 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  43. Estrogen Receptors and Enzymes Involved in Estrogen Synthesis as Breast Cancer Treatment Targets
    Barbara E. Licznerska, Hanna Szaefer, Hanna Sobierajska, Wanda Baer‐Dubowska · 2026 · International Journal of Molecular Sciences
  44. Grundlagen der parakrinen, autokrinen und intrakrinen Regulation endokriner Organe
    Josef Köhrle · 2006 · Springer eBooks
  45. Study of women veterans in menopause
    Patricia A. Rouen · 2009 · Deep Blue (University of Michigan)